Circulating HPV DNA as a Marker for Early Detection of Relapse in Patients with Cervical Cancer.
Emmanuelle JeannotAurélien LatoucheClaire BonneauMarie-Ange CalméjaneCorine BeaufortKirsten Ruigrok-RitstierGuillaume BataillonLinda Larbi ChérifCelia DupainCharlotte LecerfMarina PopovicAnne de la RochefordièreFabrice LecuruVirginie FourchotteEkaterina S JordanovaHeiko von der LeyenCarine Tran-PerennouMarie-Emmanuelle LegrierSylvain DureauLaurence RaizonvilleDiana Bello RoufaiChristophe Le TourneauIvan BiècheRoman RouzierEls M J J BernsMaud KamalSuzy SchollPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2021)
HPV ctDNA detection is a useful marker to predict relapse in cervical cancer.See related commentary by Wentzensen and Clarke, p. 5733.